Friday, August 7, 2026

Discover the Truth of Beauty: How Rejuran is Redefining Skincare in 2026

PharmaResearch launched a video for Rejuran's campaign, emphasizing scientific truth in beauty and consumer trust in skincare.

HLB Panagene Signs Exclusive PNA Distribution Agreement in Singapore With Roche Affiliate

HLB Panajin signs exclusive distribution deal for PNA with Roche Group's subsidiary, advancing its drug development efforts.

Will South Korea’s Nuclear Ambitions Spark a Regional Arms Race? Key Insights from U.S. Senators

Four Democratic senators express concerns to Trump over nuclear proliferation in South Korea, urging no uranium enrichment or reprocessing.

Tag: high-risk pathogens

North Korea Korea Kim Military AI South Korea market relations development

Anthrax, Plague, and BSL-3 Research: South Korea Checks 47 Safety Items, CCTV, and Records

The KDCA confirmed 100% compliance with biosafety standards in inspections of high-risk pathogen facilities and BSL-3 labs.

Top News

Coupang Under Fire: How U.S. Congress Investigations Could Trigger Trade Tensions...

Jung Min Ryu - February 11, 2026

U.S. concerns over Coupang may escalate trade tensions with South Korea, while UN sanctions on North Korea face enforcement challenges.

Over Half of Top Propofol-Using Clinics in Asia Found Violating Drug...

April 8, 2026

ETRI Celebrates 50 Years: How Korea’s ICT Leader is Shaping the...

April 6, 2026

The Ultimate SNEAK Attack: North Korea Plots To Bring Down APEC’s...

October 28, 2025

Hyundai Tops U.S. Quality Survey for Second Year Straight

June 27, 2025

North Korea Sends a Loud Message—Demolishing the South’s Family Center

June 20, 2025

Kim Jong Un’s Bodyguard Overhaul: How New Leaders Are Reshaping North...

January 14, 2026

KOSPI Plummets to Lowest Since May: What’s Behind the 3.96% Drop?

July 8, 2026

- Our Sponsors Ad -

Follow us